Discontinuation report ULORIC
| Report ID | 144266 |
| Drug Identification Number | 02357380 |
| Brand name | ULORIC |
| Common or Proper name | ULORIC 80 mg Tablets |
| Company Name | TAKEDA CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | FEBUXOSTAT |
| Strength(s) | 80MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | Bottle of 30's |
| ATC code | M04AA |
| ATC description | ANTIGOUT PREPARATIONS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2021-12-31 |
| Actual discontinuation date | 2021-12-31 |
| Remaining supply date | 2021-12-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-01-04 | French | Compare |
| v3 | 2022-01-04 | English | Compare |
| v2 | 2021-08-17 | French | Compare |
| v1 | 2021-08-17 | English | Compare |
Showing 1 to 4 of 4